• Issue

    Cancer Communications: Volume 44, Issue 12

    1379-1448
    December 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Open Access

Issue Information

  • Pages: 1379-1380
  • First Published: 23 December 2024

RESEARCH HIGHLIGHT

Open Access

Exciting progress in targeted therapy innovation for unresectable stage III EGFR-mutated NSCLC: the phase III LAURA study

Ziyan Tong,  Ning Zhu,  Hong Shen,  Ying Yuan, 
  • Pages: 1381-1384
  • First Published: 10 October 2024

LETTER TO THE JOURNAL

Open Access

Genomic imprinting biomarkers for cervical cancer risk stratification

Xue Xiao,  Wei Wang,  Peng Bai,  Ying Chen,  Zhengwen Qin,  Tong Cheng,  Xing Li,  John P. Pineda,  Panying Shi,  Xiaonan Wang,  Jianhong Wang,  Lian Xu,  Xuemei Gao,  Huixian Zheng,  Lulu Yang,  Wenyi Lin,  Wenbin Huang,  Rulong Shen,  Changjun Yue,  Huixiong Xu,  Felipe Batalini,  Yang Liu,  Ning Zhou,  Yaoyao Zhang,  Hanmin Liu, 
  • Pages: 1385-1390
  • First Published: 10 October 2024

ORIGINAL ARTICLE

Open Access

Targeting the LMP1-ALIX axis in EBV+ nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti-tumor immunity

Fajian He,  Yan Gong,  Gan Tao,  Jianguo Zhang,  Qiuji Wu,  Yushuang Tan,  Yajie Cheng,  Chunsheng Wang,  Jinru Yang,  Linzhi Han,  Zhihao Wang,  Yanping Gao,  Jingyi He,  Rui Bai,  Peikai Sun,  Xiaoyan Yu,  Yajuan Zhou,  Conghua Xie, 
  • Pages: 1391-1413
  • First Published: 14 October 2024

LETTER TO THE JOURNAL

Open Access

Nine-fold variation of risk of advanced colorectal neoplasms according to smoking and polygenic risk score: Results from a cross-sectional study in a large screening colonoscopy cohort

Ruojin Fu,  Xuechen Chen,  Tobias Niedermaier,  Teresa Seum,  Michael Hoffmeister,  Hermann Brenner, 
  • Pages: 1414-1417
  • First Published: 17 October 2024
Open Access

The long-term spatiotemporal trends in lung cancer burden and its risk factors at global, regional, and national levels, 1992-2021: The Global Burden of Disease Study 2021

Zegui Tu,  Shuangsi Liao,  Caini Chen,  Caili Li,  Qipeng Hu,  Chengzhi Cai,  Yang Yu,  Jieyan Luo,  Meijuan Huang, 
  • Pages: 1418-1421
  • First Published: 18 October 2024
Open Access

IL2-mediated modulation of small extracellular vesicles secretion and PD-L1 expression: a novel perspective for neutralizing immune suppression within cancer cells

Soojeong Noh,  Suyeon Ryu,  Dokyung Jung,  Sanghee Shin,  Inseong Jung,  Sung-Min Kang,  Christine Seulki Kim,  Sung-Jin Choi,  Hanchae Cho,  Melanie Schwämmle,  Youngtae Jeong,  Felicitas Bucher,  Il-Kyu Choi,  Shin Yup Lee,  Sin-Hyeog Im,  Kyungmoo Yea,  Moon-Chang Baek, 
  • Pages: 1422-1426
  • First Published: 23 October 2024
Open Access

Acquired RD3 loss regulates immune surveillance in high-risk and therapy defying progressive neuroblastoma

Poorvi Subramanian,  Sreenidhi Mohanvelu,  Dinesh Babu Somasundaram,  Sheeja Aravindan,  Natarajan Aravindan, 
  • Pages: 1427-1430
  • First Published: 24 October 2024

ORIGINAL ARTICLE

Open Access

HLX07 alone or combined with serplulimab, cisplatin and 5-fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study

Yun Liu,  Yanfeng Wang,  Yanrong Zhu,  Tao Wu,  Zhenyang Liu,  Jin Zhou,  Yuan Yuan,  Mudan Yang,  Bo Liu,  Zhenbo Tan,  Wu Zhuang,  Jiayan Chen,  Ning Li,  Ying Wang,  Xuhui Hu,  Lin Wang,  Haoyu Yu,  Qingyu Wang,  Jun Zhu,  Jing Huang, 
  • Pages: 1431-1443
  • First Published: 24 October 2024

LETTER TO THE JOURNAL

Open Access

Engineering heavy chain antibody-drug conjugates against solid tumors for a one-shot kill

Xue Liu,  Wenjing Ning,  Lei Wang,  Han Liu,  Hongye Zeng,  Xiaojing Qin,  Yuanzhi Chen,  Fentian Chen,  Lin Xu,  Yang Zhao,  Xiaoqing Chen,  Jixian Tang,  Yunlong Ren,  Xiaowen Yan,  Wenxin Luo,  Ningshao Xia, 
  • Pages: 1444-1448
  • First Published: 25 October 2024